Brooklyn Investment Group’s Encompass Health EHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$856K Buy
8,846
+603
+7% +$61.8K 0.03% 655
2025
Q4
$890K Buy
8,243
+4,707
+133% +$546K 0.04% 393
2025
Q3
$432K Buy
3,536
+29
+0.8% +$3.45K 0.06% 319
2025
Q2
$430K Buy
3,507
+3,302
+1,611% +$377K 0.06% 331
2025
Q1
$20.8K Buy
205
+167
+439% +$16.3K ﹤0.01% 1151
2024
Q4
$3.51K Buy
38
+3
+9% +$295 ﹤0.01% 1318
2024
Q3
$3.38K Buy
+35
New +$3.15K ﹤0.01% 891

Other funds holding EHC

Brooklyn Investment Group's EHC Position: Q1 2026 in Review

Brooklyn Investment Group increased its Encompass Health (EHC) stake by 7.3% in Q1 2026, buying an estimated $61.8K and bringing the position to 8,846 shares worth $856K. The position accounts for 0.03% of the portfolio, ranked #655.

Brooklyn Investment Group first reported a position in EHC in Q3 2024 and has held it in 7 quarters since. The position peaked at $890K in Q4 2025. 577 funds tracked by Wall St. Rank hold EHC as of Q1 2026.

  • Brooklyn Investment Group held 8,846 shares of Encompass Health worth $856K as of Q1 2026.
  • Brooklyn Investment Group bought 603 Encompass Health shares in Q1 2026, an estimated $61.8K.
  • Encompass Health made up 0.03% of Brooklyn Investment Group's portfolio in Q1 2026, its #655 holding.
  • Brooklyn Investment Group first reported a position in Encompass Health in Q3 2024 and has held it in 7 quarters since.
  • Brooklyn Investment Group's Encompass Health position peaked at $890K in Q4 2025.
  • 577 funds tracked by Wall St. Rank held Encompass Health as of Q1 2026.

Based on Brooklyn Investment Group's 13F filing for Q1 2026, filed 29 Apr 2026.